Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis

08 Apr 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Juvenile Idiopathic Arthritis · Phase 2 · Enrollment 71 · Sponsor: R-Pharm International, LLC

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Cardiology on 08 Apr 2026. The item focuses on Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis. Open the detail page to review the full original feed content.